Kawachi, Izumi http://orcid.org/0000-0002-7140-8500
Okamoto, Shuichi
Sakamoto, Mariko
Ohta, Hiroyuki
Nakamura, Yusuke
Iwasaki, Kosuke
Yoshida, Manami
Hiroi, Shinzo
Ogino, Mieko
Funding for this research was provided by:
Takeda Pharmaceutical Company Limited (none)
Article History
Received: 20 March 2019
Accepted: 19 November 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: IK has received funding for research, travel and/or speaker honoraria from Novartis Pharma, Biogen, Bayer Yakuhin Limited, Mitsubishi Tanabe Pharma, Takeda Pharmaceutical Comapany Limited, Japan Blood Products Organization and Astellas Pharma, and is a scientific advisory board member for Biogen and Takeda Pharmaceutical Company Limited. MO has received funding for travel from Takeda Pharmaceutical Company Limited. SO, MS and, HO, MY, and SH are employees of Takeda Pharmaceutical Company Limited. KI and YN areis an employees of Milliman. MY, and SH were employed by Takeda Pharmaceutical Company Limited., and YN was employed by Milliman, during the execution of this research. MO has received funding for travel from Takeda Pharmaceutical Company Limited. The authors declare that they have no competing interests.